While Diasonics set up a separate company to sell Vingmed ultrasoundscanners in the U.S. cardiology market, Siemens moved in the oppositedirection last month. The German vendor initiated consolidationof the sales and service staff of its
While Diasonics set up a separate company to sell Vingmed ultrasoundscanners in the U.S. cardiology market, Siemens moved in the oppositedirection last month. The German vendor initiated consolidationof the sales and service staff of its cardiology-focused ultrasounddivision in San Ramon, CA, with the radiology and vascular groupat Quantum Medical Systems in Issaquah, WA.
Both ultrasound offices will be retained in the consolidationprocess, and the two brand names will continue for the time being,said Lonnie Edelheit, Quantum president.
Siemens' acquisition of Quantum a year ago (SCAN 4/11/90) provideda foothold in the high-end radiology ultrasound market. Siemensbases its worldwide ultrasound business unit in the U.S.
Like most other multimodality medical imaging companies, Siemenshas had to play catch-up with smaller, dedicated ultrasound firmsthat have been successful in the technology-intensive radiologyultrasound field.
Siemens decided to combine the two sales and service groupsto provide a unified focus for its ultrasound business and improveresponsiveness to customers, Edelheit told SCAN. The unified salesand service group will handle scanners in the cardiac, radiology,vascular and ob/gyn private-office markets.
Is MRI Contrast Enhancement Necessary for Long-Term Monitoring of Diffuse Glioma?
March 4th 2025In a comparison of contrast-enhanced T1-weighted (CET1w) MRI (and T2-weighted MRI/FLAIR imaging, researchers found that only three out of 82 cases of glioma progression were solely detected with CET1w MRI.